18 Jun, 2020 Seventh Annual RNAi Roundtable Series
We are hosting a series of online “RNAi Roundtables” at which Alnylam scientists and program leaders, as well as clinical collaborators, will review recent progress in many of our pipeline programs and platform.
Click on any of the RNAi Roundtables below to listen to the webcasts and view presentations from these events.
ALN-AGT, in Development for the Treatment of Hypertension
Tuesday, June 23, 2:30 pm ET
Early Stage RNAi Therapeutics Pipeline
Friday, July 17, 9:30 am ET
Lumasiran, in Development for the Treatment of Primary Hyperoxaluria Type 1
Monday, August 10, 2:00 pm ET
Patisiran and Vutrisiran, in Development for the Treatment of ATTR Amyloidosis
Thursday, September 3, 12:00 pm ET
Givosiran, for the Treatment of Acute Hepatic Porphyria
Monday, September 14, 1:30 pm ET
